NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
0.735
-0.015 (-1.97%)
At close: Mar 10, 2025, 4:00 PM
0.702
-0.033 (-4.52%)
Pre-market: Mar 11, 2025, 7:16 AM EST
NextCure Employees
NextCure had 82 employees as of December 31, 2023. The number of employees decreased by 17 or -17.17% compared to the previous year.
Employees
82
Change (1Y)
-17
Growth (1Y)
-17.17%
Revenue / Employee
n/a
Profits / Employee
-$678,707
Market Cap
20.59M
Employees Chart
NXTC News
- 4 days ago - NextCure Provides Business Update and Reports Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers - GlobeNewsWire
- 3 months ago - NextCure Announces Acceptance of IND Application for LNCB74 - GlobeNewsWire
- 3 months ago - NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta - GlobeNewsWire
- 4 months ago - NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 5 months ago - NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire